LONDON, May 7 (Reuters) - Britain's decision to advise all
under 40-year-olds to take an alternative vaccine to the
Oxford/AstraZeneca one will not affect the country's plan to
offer a first dose to all adults by the end of July, a senior
health official said on Friday.
"I can say to you that on current plans, our vaccine supply
schedule will support the change offered by the (vaccine
advisory group) JCVI without limiting the speed and scale of the
vaccine rollout," England's Deputy Chief Medical Officer
Jonathan Van-Tam told a news conference.
"I do expect that we are still on target to offer a first
dose to all adults by the end of July."
(Reporting by Sarah Young and Paul Sandle; writing by Kate
Holton; editing by Michael Holden)